Eslicarbazepine is an aromatic anticonvulsant similar to oxcarbazepine that is used in combination with other antiepileptic agents as therapy of partial onset seizures. Eslicarbazepine is associated with a low rate of transient serum enzyme elevations during therapy and has been implicated in rare instances of clinically apparent liver injury. Its therapeutic use is listed as central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include (S)-Licarbazepine and Eslicarbazepina. Its PubChem CID is 9881504.
Eslicarbazepine
| CAS No | 104746-04-5 |
|---|---|
| Molecular Formula | C15H14N2O2 |
| Molecular Weight | 254.28 g/mol |
| Synonyms | (5S)-5-hydroxy-5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Eslicarbazepine is an aromatic anticonvulsant similar to oxcarbazepine that is used in combination with other antiepileptic agents as therapy of partial onset seizures.
The listed CAS number is 104746-04-5.
The listed molecular formula is C15H14N2O2.
The listed molecular weight is 254.28 g/mol.
(5S)-5-hydroxy-5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide.
The source lists (S)-Licarbazepine and Eslicarbazepina.